台股 » 個股 » 和康生 » 籌碼相關 » 券商分點績效

和康生

(1783)
可現股當沖
  • 股價
    42.25
  • 漲跌
    ▲0.05
  • 漲幅
    +0.12%
  • 成交量
    175
  • 產業
    上市 生技醫療類股
  • 129人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
和康生 (1783)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/05/09 ~ 2024/05/16     後一日»

券商獲利排行 - 2024/05/09 ~ 2024/05/16

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  2.14%37.8037.8-4004143.243.143.242.3
  2.16%16.8016.8-1801843.2043.242.3
  2.73%16.58.67.9-581443.242.543.642.3
  3.00%13.1013.1-1001043.6043.642.3
  2.62%12.5012.5-1101143.4043.442.3
  2.64%11.5011.5-1001043.4043.442.3
  2.61%10.2010.2-90943.4043.442.3
  1.69%7.225.3-731042.842.34342.3
  1.52%6.506.5-1001042.9042.942.3
  2.86%6.21.25-41543.342.343.542.3
  2.02%6.106.1-70743.1043.142.3
  2.22%5.805.8-60643.2043.242.3
  2.99%5.205.2-40443.6043.642.3
  1.97%5.105.1-60643.1043.142.3
  2.31%505-40543.343.643.342.3
  2.31%50.44.6-41543.34343.442.3
  2.20%4.804.8-40543.243.843.242.3
  0.92%4.704.7-1201242.6042.642.3
  2.68%4.704.7-40443.4043.442.3
  1.44%4.4-0.54.9-43743.543.743.542.3
  3.21%4.204.2-30343.6043.642.3
  1.92%4.20.24-41543.243.143.242.3
  2.37%4.104.1-40443.3043.342.3
  1.68%3.603.6-5054304342.3
  2.69%3.503.5-30343.4043.442.3
  0.40%3.53.500202043.343.243.442.3
  1.97%3.403.4-40443.1043.142.3
  2.61%3.403.4-30343.4043.442.3
  1.55%3.3-0.33.6-41543.243.443.242.3
  2.54%3.303.3-30343.4043.442.3
  2.54%3.303.3-30343.4043.442.3
  2.46%3.203.2-30343.3043.342.3
  2.46%3.203.2-30343.3043.342.3
  0.90%3.1-0.83.9-44843.343.443.242.3
  3.53%3.103.1-20243.843.343.842.3
  1.42%303-50542.943.342.942.3
  1.40%303-50542.9042.942.3
  3.32%2.902.9-20243.7043.742.3
  2.24%2.902.9-30343.2043.242.3
  3.21%2.802.8-10243.643.143.742.3
  3.15%2.702.7-20243.6043.642.3
  2.09%2.702.7-30343.2043.242.3
  2.99%2.602.6-20243.6043.642.3
  1.97%2.602.6-30343.1043.142.3
  1.93%2.502.5-30343.1043.142.3
  2.59%2.302.3-20243.4043.442.3
  2.42%2.102.1-20243.3043.342.3
  2.23%20.41.5-11243.643.443.842.3
  0.35%1.901.9-1301342.4042.442.3
  2.20%1.901.9-20243.2043.242.3

券商虧損排行 - 2024/05/09 ~ 2024/05/16

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -1.20%-31.1-2.7-28.432602743.143.14342.3
  -2.08%-30.6-1.6-28.92734743.343.343.142.3
  -2.18%-29.30-29.33031043.243.24342.3
  -3.15%-27.50-27.52020043.643.6042.3
  -2.31%-140-141414043.343.3042.3
  -3.61%-12.70-12.788043.843.8042.3
  -1.40%-120-122020042.942.9042.3
  -2.70%-10.60-10.689043.443.443.242.3
  -2.11%-100-101111043.243.2042.3
  -2.79%-9.70-9.788043.543.5042.3
  -1.24%-8.6-1.7-6.96161043.343.443.242.3
  -1.87%-8.10-8.11010043.143.1042.3
  -2.44%-7.40-7.467043.343.34342.3
  -0.47%-7.13.3-10.412352343.243.143.342.3
  -1.92%-6.60-6.688043.143.1042.3
  -2.76%-60-655043.543.5042.3
  -2.10%-5.40-5.466043.243.2042.3
  -2.47%-5.40-5.455043.343.3042.3
  -1.23%-5.3-1.8-3.6310743.343.443.242.3
  -2.01%-5.20-5.266043.143.1042.3
  -2.82%-4.90-4.944043.543.5042.3
  -2.45%-4.30-4.344043.343.342.442.3
  -3.21%-4.20-4.233043.743.7042.3
  -2.42%-4.20-4.234043.343.342.442.3
  -2.37%-4.10-4.144043.343.3042.3
  -0.34%-3.7-0.2-3.55252042.942.942.942.3
  -1.14%-3.4-1.1-2.427543.343.443.242.3
  -3.32%-2.90-2.922043.743.7042.3
  -0.39%-2.93.2-6.17171043.243.143.442.3
  -2.99%-2.60-2.622043.643.6042.3
  -1.50%-2.6-0.3-2.324243.343.443.242.3
  -1.97%-2.60-2.633043.143.1042.3
  -0.78%-2.40.2-2.637443.143.143.242.3
  -2.42%-2.10-2.122043.343.3042.3
  -0.51%-20.7-2.739643.243.143.342.3
  -0.51%-2-0.1-1.929743.243.243.242.3
  -1.11%-1.90-1.944042.742.7042.3
  -2.20%-1.90-1.922043.243.2042.3
  -2.09%-1.80-1.812043.243.243.542.3
  -2.09%-1.80-1.822043.243.2042.3
  -2.09%-1.80-1.822043.243.2042.3
  -3.76%-1.70-1.711043.943.9042.3
  -3.54%-1.60-1.611043.843.8042.3
  -3.54%-1.60-1.611043.843.8042.3
  -3.43%-1.50-1.511043.843.8042.3
  -0.35%-1.50-1.51010042.442.4042.3
  -1.11%-1.4-0.2-1.203243.443.543.442.3
  -3.21%-1.40-1.411043.743.7042.3
  -3.14%-1.40-1.411043.643.6042.3
  -2.99%-1.30-1.311043.643.6042.3
〈大江集團法說〉和康生明年營收續拚雙位數成長 淨利率維持25%Anue鉅亨-2023/11/20
和康生三大業務銷售看旺 明、後年將啟動擴產計畫Anue鉅亨-2023/07/25
和康生全年毛利率有望維持67%水準 今年將取得10張認證Anue鉅亨-2023/05/23
和康生 相關文章